Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Cancers|April 10, 2019
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-AnalysisSara Pusceddu, Michele Ghidini, Martina Torchio, et al.
Journal of Clinical Medicine|February 15, 2022
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective StudyAngela Dalia Ricci, Sara Pusceddu, Francesco Panzuto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2024
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATEMarco Maccauro, Mariarosaria Cuomo, Matteo Bauckneht, et al.
Endocrine|December 2, 2016
Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumorsMassimo Milione, Patrick Maisonneuve, Alessio Pellegrinelli, et al.
International Journal of Cancer|December 7, 2018
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)Claudio Vernieri, Sara Pusceddu, Giovanni Fucà, et al.
Journal of Neuroendocrinology|July 16, 2021
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging noveltiesKetevani Kankava, Patrick Maisonneuve, Alessandro Mangogna, et al.
Journal of Clinical Medicine|May 9, 2020
Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter AnalysisGiuseppe Lamberti, Maria Pia Brizzi, Sara Pusceddu, et al.
Frontiers in Oncology|July 5, 2021
Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell CarcinomaMartina Torchio, Laura Cattaneo, Massimo Milione, et al.
Therapeutic Advances in Gastroenterology|August 22, 2020
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidenceSara Pusceddu, Claudio Vernieri, Natalie Prinzi, et al.
Future Oncology (London, England)|August 20, 2019
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETsNatalie Prinzi, Alessandra Raimondi, Marco Maccauro, et al.
Pageof 12